Recurrence Rate of Minimally Invasive Endoscopic Treatment of Internal Hemorrhoids
NCT ID: NCT06250140
Last Updated: 2024-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
900 participants
OBSERVATIONAL
2024-02-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2.2 Secondary objective: To observe the safety and efficacy of endoscopic minimally invasive treatment of internal hemorrhoids
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Two Treatment Methods Compared the Sclerosing Agent Injection and the Rubber Wrapping
NCT05089500
Comparison of the Clinical Efficacy and Safety of Endoscopic Superior Rectal Mucosal Ligation and Hemorrhoids Ligation
NCT06649786
Endoscopic Rubber Band Ligation and Milligan-Morgan Hemorrhoidectomy for the Treatment of Grade II-III Internal Hemorrhoids: a Multicenter, Non-randomized Controlled Study
NCT06794151
A Study on the Endoscopic Treatments of Hemorrhoids
NCT05268575
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse
NCT03917056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Internal hemorrhoid ligation group
Endoscopic internal hemorrhoid ligation
Tie up device
The recurrence rate of internal hemorrhoids in different treatment methods
Hemorrhoids injection group
Endoscopic hemorrhoid injection was performed
Tie up device
The recurrence rate of internal hemorrhoids in different treatment methods
Internal hemorrhoids combined treatment group
Lines of endoscopic hemorrhoids and internal ligation under endoscope to injection
Tie up device
The recurrence rate of internal hemorrhoids in different treatment methods
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tie up device
The recurrence rate of internal hemorrhoids in different treatment methods
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2, grade I-III internal hemorrhoids with symptoms related to internal hemorrhoids
3\. The purpose and adverse consequences of endoscopic minimally invasive treatment of internal hemorrhoids have been fully understood before surgery, and the informed consent for endoscopic minimally invasive treatment of internal hemorrhoids has been signed
Exclusion Criteria
Degree of internal hemorrhoids with incarceration, thrombosis, erosion, infection, etc. (3) patients with severe systemic diseases could not tolerate endoscopic treatment; (4) accompanied by crissum infectious disease, anal fistula, and inflammatory bowel disease activity, etc.; (5) in menstrual period, pregnancy and puerperium, (6) patients with sclerotherapy allergy; (7) function of blood coagulation disorder or are using anticoagulant drugs.
2\. Patients with a history of allergy to narcotic drugs
3\. Patients who were deemed by the investigator to be ineligible for participation in the trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
964 hospital of joint Logistics Support Force
UNKNOWN
The Chinese people's liberation army army medical center
UNKNOWN
Shenzhen Hospital of Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ying Zhu
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ShenzhenH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.